Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (odpre novo okno)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

Vir‎: Pediatr Transplant 2017;21(6):e13017.

Indeksirano‎: PubMed 28653480

DOI‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (odpre novo okno)

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (odpre novo okno)

Bhatia M, Davenport V, Cairo MS.

Vir‎: Leuk Lymphoma 2007;48(1):9-15.

Indeksirano‎: PubMed 17325843

DOI‎: 10.1080/10428190600909115

https://www.ncbi.nlm.nih.gov/pubmed/17325843 (odpre novo okno)

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (odpre novo okno)

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Vir‎: Lancet 2003;361(9354):275-80.

Indeksirano‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860 (odpre novo okno)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (odpre novo okno)

Fassel H, Bussel JB, Roberts SS, Modak S

Vir‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

Indeksirano‎: PubMed 29683946

DOI‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (odpre novo okno)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (odpre novo okno)

Jacobson AE, Shah N, Setty BA

Vir‎: Pediatr Blood Cancer 2017;64(8):e26473.

Indeksirano‎: PubMed 28150377

DOI‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (odpre novo okno)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (odpre novo okno)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

Vir‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

Indeksirano‎: PubMed 30080752

DOI‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (odpre novo okno)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (odpre novo okno)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

Vir‎: Int J Hematol 2015;102(5):626-32.

Indeksirano‎: PubMed 26084627

DOI‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (odpre novo okno)

Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial. (odpre novo okno)

Porter JC, Leahey A, Polise K, Bunin G, Manno CS

Vir‎: J Pediatr 1996;129(5):656-60.

Indeksirano‎: PubMed 8917229

DOI‎: 10.1016/s0022-3476(96)70145-2

https://www.ncbi.nlm.nih.gov/pubmed/8917229 (odpre novo okno)

Chemotherapy induced thrombocytopenia in pediatric oncology. (odpre novo okno)

Tamamyan G, Danielyan S, Lambert MP

Vir‎: Crit Rev Oncol Hematol 2016;99:299-307.

Indeksirano‎: PubMed 26811139

DOI‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (odpre novo okno)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (odpre novo okno)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

Vir‎: Onkologie 2004;27(2):131-7.

Indeksirano‎: PubMed 15138344

DOI‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (odpre novo okno)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (odpre novo okno)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Vir‎: Ann Oncol 2005;16(1):139-45.

Indeksirano‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (odpre novo okno)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (odpre novo okno)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

Vir‎: Blood 1998;91(10):3601-6.

Indeksirano‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (odpre novo okno)